Japan-based pharmaceutical giant Takeda currently faces more than 8,000 Actos lawsuits that accuse the company of concealing bladder cancer risks. Most of these complaints have been coordinated in Louisiana federal court, as a part of multidistrict litigation, where a landmark Actos lawsuit award was rendered in the case of Terrence... Read more »

Pharmaceutical giant Pfizer and Greenstone LLC have been named defendants in a Lipitor diabetes lawsuit brought by Rosemary and Drew Reynolds. The Florida couple’s case was filed via short form complaint to be consolidated in the Lipitor Products Liability Litigation underway in Charleston, South Carolina. The Lipitor MDL 2502 has... Read more »

Low T drug lawsuits alleging life-altering complications from Androgel, Testim and other testosterone supplements continue to mount in courtrooms across the nation. Plaintiffs claim they were inadequately warned about the risk of cardiovascular injury, stroke, heart attack and other severe health complications by the manufacturers of testosterone replacement products. A... Read more »

Pharmaceutical giant Bayer has already resolved more than 17,000 Yaz and Yasmin lawsuits involving venous clot injuries, pulmonary embolism and deep vein thrombosis, but hundreds more are still pending in multidistrict litigation No. 2100. While the MDL is still marshalling discovery common to all cases, the presiding Judge, Honorable David... Read more »

Judge Cynthia Rufe, who is overseeing MDL No. 2342 in the U.S. District Court for the Eastern District of Pennsylvania, recently remanded a Zoloft lawsuit back to Missouri state court, reports Harris Martin. The MDL judge found that the 25 claimant families did not fraudulently misjoin their complaints into a... Read more »

Dara Goldstein, individually and as successor in interest of the estate of Samuel Goldstein, has submitted a short form complaint for monetary damages against Merck, Sharpe & Dohme. The plaintiff claims that her now deceased husband developed pancreatic cancer and subsequently died as a direct result of taking the diabetes... Read more »

The Los Angeles Superior Court is the site of a new product liability suit involving Bayer’s birth control pills marketed under the brand names Yaz and Yasmin. The controversial oral contraceptives, made with a fourth-generation progestin known to increase blood clot formation, have been associated with life-threatening health complications including... Read more »

Angiotensin II type 1 receptor blockers (ARBs) are commonly used in the treatment of hypertension (high blood pressure) and heart failure. Benicar, manufactured by Daiichi Sankyo, is one of the more widely prescribed ARBs since its FDA approval in 2002. Also known by its generic name olmesartan medoxomil, Benicar has... Read more »

The atypical antipsychotic Risperdal continues to fuel litigation, as scores of male patients claim they developed breasts after taking the drug as children and adolescents. Court dockets indicate some 500 Risperdal lawsuits pending against pharmaceutical giant Johnson & Johnson, which has already settled a handful of claims (under confidential terms)... Read more »

On May 21, 2014, Fresenius Medical Care announced an expanded Naturalyte recall due to bacterial contamination.  The product recall was first issued in April after Halomonas bacteria was found in several lots of the dialysate additive.  The amended Class I recall now affects 56 lots of Naturalyte. The acid concentrates,... Read more »